The contrast exposed a difference between how Washington, D.C., typically assesses nominees to lead the Department ... Warren’s Massachusetts houses many drug companies, including Moderna, maker of an ...

Check out this morning’s top movers from around Wall Street, compiled by The Fly. Maximize Your Portfolio with Data Driven Insights:Leverage ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

09:35 EST Moderna (MRNA) trading halted, volatility trading pause Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed ...

Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, a person close to the matter told Fierce Pharma. The layoffs are ...

PARIS, Jan 28 (Reuters) - Chanel assembled a sprawling runway set in the form of its trademark interlocking C logo for its spring summer 2025 catwalk show, held on Tuesday at the Grand Palais in ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

Moderna secures a multi-year agreement to supply its COVID-19 vaccine to 17 European countries, including Norway and North Macedonia. Vaccine formats include prefilled syringes, reducing ...

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

As of noon yesterday, the White House has adopted a new logo that will appear everywhere from the administration’s website to official letterheads and the backdrop of press briefings.

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...